| Strategic consulting services are critical to non-US developers of emerging and innovative technologies and services. The Pharmaceutical, medical device and biotech markets are well-know for their conservative position and avoidance of risk. BCM Group serves as the eyes and ears of the manufacturer, a scout with highly-developed skill for identifying new opportunities and potential markets.
BCM Group’s track record in new business development spans decades of work in the Pharma and biotech industries. New market development opportunities continually emerge for long term and highly profitable relationships with US customers. Being close to the market –physically and culturally is essential to being considered a reliable partner to the industry.
European manufacturers recognize the market and business potential the US offers. Many have gone at it alone, only to be discouraged due to misunderstanding the business culture, or missing opportunities due to communication limitations. BCM Group removes these and other commonly-encountered barriers to building a sound business.
The life sciences market is a relationship-based business culture. The introduction and sales of new products manufactured overseas requires a level of experience and understanding which BCM offers. The market affords little margin for error.
As the client European company begins to enjoy sustainable business activities in the US, BCM Group offers Phase II Business Management Consulting. The manufacturer can think confidentially that their interests are being watched carefully and the day-to-day activities are under control and communicated in a accurate and timely manner by BCM Group.
BCM Group can screen and recommend new locally based employees, train sales personnel, establish key account strategies and oversee local project management.
|
